Leerink Partners Maintains Market Perform on Medpace Hldgs, Lowers Price Target to $485

Medpace +1.48%

Medpace

MEDP

450.41

+1.48%

Leerink Partners analyst Michael Cherny maintains Medpace Hldgs (NASDAQ: MEDP) with a Market Perform and lowers the price target from $575 to $485.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via